Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: Subanalysis of the EMPA-REG OUTCOME randomised trial
Diabetologia - Clinical and Experimental Diabetes and Metabolism | Jul 11, 2018
A randomised clinical trial comparing N-butyl cyanoacrylate, radiofrequency ablation and endovenous laser ablation for the treatment of superficial venous incompetence: Two year follow up results
European Journal of Vascular and Endovascular Surgery | Jul 11, 2018
Most read this week